Shahida Yakoob Mohammad, MD
Family Medicine · San Jose
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 3
- 2 carriers
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plans that list them
3 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Mohammad’s office at (408) 270-2100 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
3 of 3 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
Medicaid work
$12,845 in 2024
Medicaid paid $12,845 for 758 billed services this clinician did in 2024, up to 46 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Developmental screening | 260 | $10,303 |
| Pure tone audiometry (threshold); air only | 94 | $885 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 16 | $574 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 14 | $330 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 16 | $279 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 30 | $208 |
| Short return visit (20+ min) | 304 | $191 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 24 | $76 |
| 2024 | 758 | 8 | 46 | $12,845 |
| 2023 | 1,497 | 9 | 65 | $21,855 |
| 2022 | 1,684 | 9 | 65 | $26,141 |
| 2021 | 1,565 | 11 | 66 | $25,844 |
| 2020 | 1,468 | 9 | 62 | $24,998 |
| 2019 | 2,375 | 11 | 73 | $34,302 |
| 2018 | 1,427 | 8 | 59 | $22,147 |
See the largest Medicaid services in earlier years
2023
| Developmental screening | 377 | $15,334 |
| Pure tone audiometry (threshold); air only | 192 | $2,036 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 73 | $1,904 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 29 | $1,156 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 105 | $783 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 99 | $296 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 12 | $246 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 13 | $99 |
| Short return visit (20+ min) | 597 | $0 |
2022
| Developmental screening | 455 | $18,739 |
| Pure tone audiometry (threshold); air only | 180 | $1,979 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 71 | $1,858 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 34 | $1,211 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 37 | $1,068 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 88 | $644 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 137 | $404 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 43 | $238 |
| Short return visit (20+ min) | 639 | $0 |
2021
| Developmental screening | 434 | $17,011 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 106 | $2,788 |
| Pure tone audiometry (threshold); air only | 225 | $2,347 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 42 | $1,642 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 108 | $709 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 15 | $451 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 143 | $439 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 22 | $179 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 17 | $139 |
| Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, diphtheria toxoid carrier (MenACWY-D) or CRM197 carrier (MenACWY-CRM), for intramuscular use | 17 | $139 |
| Short return visit (20+ min) | 436 | $0 |
2020
| Developmental screening | 396 | $16,283 |
| Pure tone audiometry (threshold); air only | 215 | $2,453 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 68 | $2,229 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 42 | $1,596 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 152 | $1,068 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 27 | $783 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 140 | $450 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 12 | $89 |
| Short return visit (20+ min) | 416 | $47 |
2019
| Developmental screening | 575 | $22,772 |
| Pure tone audiometry (threshold); air only | 390 | $3,776 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 105 | $3,253 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 62 | $1,278 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 166 | $1,236 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 284 | $974 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 26 | $825 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 25 | $188 |
| Health and behavior assessment | 14 | $0 |
| Health and behavior assessment (eg, health-focused clinical interview, behavioral observations, psychophysiological monitoring, health-oriented questionnaires), each 15 minutes face-to-face with the patient; re-assessment | 45 | $0 |
| Short return visit (20+ min) | 683 | $0 |
2018
| Developmental screening | 435 | $16,244 |
| Pure tone audiometry (threshold); air only | 236 | $2,218 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 32 | $1,254 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 28 | $948 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 135 | $823 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 182 | $660 |
| Health and behavior assessment | 83 | $0 |
| Short return visit (20+ min) | 296 | $0 |
Money from drug and device companies
$20 in 2022
A payment is not proof that care is biased.
| Janssen Pharmaceuticals | Ponvory | $20 | 1 payment
|
See the published payment
| Janssen Pharmaceuticals | Meals · 2022-06-08 | Ponvory | $20 |
Professional record
- NPI
- 1255426565
- Licence
- CA A511160
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X); Pediatrics (208000000X)
- Mailing address
- 2728 Aborn Road, San Jose, CA, 95121
- NPI first listed
- 2006-10-03
- NPI last updated
- 2025-09-11
This is when the NPI record was last certified, not a medical board exam.